Transplant Rx at facility.YYY:Type:Pt:Cancer.XXX:Nom: - CISMeF
Transplant Rx at facility.YYY:Type:Pt:Cancer.XXX:Nom:LOINC code
Preferred Label : Transplant Rx at facility.YYY:Type:Pt:Cancer.XXX:Nom:;
LOINC status : ACTIVE;
LOINC long common name : Transplant treatment at facility.YYY Cancer;
LOINC short name : Transplant Rx at facility Cancer;
LOINC description : Records whether immunotherapeutic agents (biologic response modifiers) were administered
as first-course treatment at this facility or the reason they were not given. Immunotherapy
consists of biological or chemical agents that alter the immune system or change the
host's response to tumor cells. Systemic therapy may involve the administration of
one or a combination of agents. This data item allows for the evaluation of the administration
of immunotherapeutic agents as part of the first course of therapy. If central registries
wish to study the treatment given at particular hospitals, the hospital-level treatment
fields must be used. The summary treatment fields, conversely, combine information
across all hospitals that provide first course of treatment for the tumor. Hospital-specific
fields allow studies of detailed referral patterns and treatment by type of hospital.
Knowing what part of the treatment was given at a particular hospital also helps resolve
coding issues... NAACCR Data Standards and Data Dictionary Version 11;